Endo International plc (Endo) is a global specialty healthcare company focused on branded and generic pharmaceuticals and devices. The Company operates in four segments: U.S. Branded Pharmaceuticals, U.S. Generic Pharmaceuticals, Devices and International Pharmaceuticals. U.S. Branded Pharmaceuticals segment includes brand names, such as Lidoderm, Opana ER, Voltaren Gel, Percocet, Fortesta Gel and Natesto, among others. Non-branded U.S. Generic Pharmaceuticals portfolio consists of products, focused in pain management. Devices segment focuses on providing technology solutions to physicians treating men’s and women’s pelvic health conditions and operates in the business lines: men’s health, women’s health, and benign prostatic hyperplasia therapy. International Pharmaceuticals segment includes a variety of specialty pharmaceutical products and certain medical devices for the Canadian, Latin American, South African and world markets.